CIK 0001636651 · Non-accelerated filer<br>Smaller reporting company
Ovid Therapeutics Inc.
Sign in to watch- Ticker
- OVID
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 465270895
- Phone
- 212-776-4381
- Business address
- 441 NINTH AVENUE, 14TH FLOOR, NEW YORK, NY, 10001
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 61 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-15 | LEVIN JEREMY M CEO | Conversion · Series B Convertible Preferred Stock | −71 | 0 | ||
| 2025-12-11 | LEVIN JEREMY M CEO | Purchase · Series B Convertible Preferred Stock | +71 | 71 | ||
| 2025-12-11 | LEVIN JEREMY M CEO | Purchase · Series A Warrant (right to buy) | +47,333 | 47,333 | ||
| 2025-12-11 | LEVIN JEREMY M CEO | Purchase · Series B Warrant (right to buy) | +35,500 | 35,500 | ||
| 2025-12-08 | TAKEDA PHARMACEUTICAL CO LTD 10% owner | Conversion | +1,250,000 | 7,000,000 | ||
| 2025-12-08 | TAKEDA PHARMACEUTICAL CO LTD 10% owner | Conversion · Series A Convertible Preferred Stock | −1,250 | 0 | ||
| 2025-03-03 | PAPADOPOULOS STELIOS Director | Grant or award · Stock Option (right to buy) | +90,000 | 90,000 | ||
| 2025-02-26 | ALEXANDER MARGARET A. President and COO | Sale | −5,279 | $0.56 | $3K | 73,406 |
| 2025-02-26 | Rona Jeffrey A CBFO | Sale | −3,902 | $0.56 | $2K | 67,973 |
| 2025-02-20 | Fitzgerald Kevin Joseph Director | Grant or award · Stock Option (right to buy) | +45,000 | 45,000 | ||
| 2025-02-20 | Friedman Bart Director | Grant or award · Stock Option (right to buy) | +45,000 | 45,000 | ||
| 2025-02-20 | Duncan Barbara Gayle Director | Grant or award · Stock Option (right to buy) | +45,000 | 45,000 | ||
| 2025-02-20 | Bernstein Karen Director | Grant or award · Stock Option (right to buy) | +45,000 | 45,000 | ||
| 2025-02-20 | LEVIN JEREMY M CEO | Grant or award · Employee Stock Option (Right to Buy) | +1,650,000 | 1,650,000 | ||
| 2025-02-20 | Rona Jeffrey A CBFO | Grant or award | +43,750 | 71,875 | ||
| 2025-02-20 | Rona Jeffrey A CBFO | Grant or award · Employee Stock Option (Right to Buy) | +262,500 | 262,500 | ||
| 2025-02-20 | ALEXANDER MARGARET A. President and COO | Grant or award | +43,750 | 78,685 | ||
| 2025-02-20 | ALEXANDER MARGARET A. President and COO | Grant or award · Employee Stock Option (Right to Buy) | +262,500 | 262,500 | ||
| 2025-01-27 | ALEXANDER MARGARET A. President and COO | Purchase | +6,810 | $0.73 | $5K | 34,935 |
| 2024-12-12 | Fitzgerald Kevin Joseph Director | Grant or award · Stock Option (Right to Buy) | +90,000 | 90,000 |
Page 2 of 7 · 123 trades